1.00494
Parteck® M 100 (Mannitol)
EMPROVE® ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, E 421
Synonyma:
D-Mannitol
Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen
About This Item
Empirický vzorec (Hillův zápis):
C6H14O6
CAS Number:
Molekulová hmotnost:
182.17
MDL number:
UNSPSC Code:
12352107
E Number:
E421
EC Index Number:
200-711-8
Technický servis
Potřebujete pomoc? Náš tým zkušených odborníků je vám k dispozici.
Dovolte nám, abychom vám pomohliTechnický servis
Potřebujete pomoc? Náš tým zkušených odborníků je vám k dispozici.
Dovolte nám, abychom vám pomohliagency
BP
ChP
JP
Ph. Eur.
USP
Quality Level
product line
EMPROVE® ESSENTIAL
form
fine powder
autoignition temp.
410 °C
quality
E 421
particle size
(see specification)
pH
5-7 (20 °C, 100 g/L in H2O)
bp
290-295 °C/4 hPa
mp
164-169 °C
solubility
213 g/L
application(s)
liquid formulation
pharmaceutical
solid formulation
storage temp.
2-25°C
SMILES string
OC(C(O)C(O)CO)C(O)CO
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2
InChI key
FBPFZTCFMRRESA-UHFFFAOYSA-N
General description
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Parteck® M excipient achieves excellent compressibility while keeping the API stable throughout your manufacturing process and beyond. Based on directly compressible mannitol, it does not require further processing or high compression forces. The unique and large surface area of Parteck® M excipient enables rapid disintegration and quick release regardless of the dosage. It is well suitable for tableting processesusing direct compression or granulation techniques such as wet granulation androller compaction. Parteck® M is available in different particle sizes.
Features and Benefits
- High compactibility at low compression forces
- Rapid disintegration and fast dissolution
- High dilution potential
- Non-hygroscopic, exceptionally low content of reducing sugars
- Uniform doses with homogenous distribution
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under Parteck® M 100 (Mannitol)
Skladovací třída
11 - Combustible Solids
wgk_germany
WGK 1
Osvědčení o analýze (COA)
Vyhledejte osvědčení Osvědčení o analýze (COA) zadáním čísla šarže/dávky těchto produktů. Čísla šarže a dávky lze nalézt na štítku produktu za slovy „Lot“ nebo „Batch“.
Již tento produkt vlastníte?
Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.